Cefuroxime is a new broad spectrum cephalosporin antibiotic for parenteral administration. It has a high degree of stability against most f-lactamases, including complete stability against penicillinase (O'Callaghan et al. 1976) . Unlike many cephalosporins, it is also highly active against Heemophilus influenza? (Meunier-Carpen- tier & Klastersky 1978; Norrby et al. 1976 ) an advantage in treating respiratory tract infections. It gives reliable serum concentrations after i.m. injection and local tolerance in connection with this administration route has been g6od in human volunteers (Foord 1976) . The aim of this open study was to investigate the effect and tolerance of cefuroxime in clinical infections in man.
MATERIAL AND METHODS

Patients
Eighteen adult patients hospitalized for moderate to severe acute infections were included in the study, 12 women and 6 men. The mean age was 62.6 years (range 33-86 years). Clinical and roentgenological examination was carried out at the start of the trial and the patients were observed daily through the treatment period. Further examination was performed at follow-up 2-4 weeks after treatment.
The clinical type of infection is shown in Table  I . Fourteen patients had pneumonia or bronchopneumonia and were considered to be in need of parenteral antibiotic treatment. In addition, they had general supportive treatment and physiotherapy. Four patients were treated for renal infections. Most of the patients had chronic concurrent diseases such as alcoholism (2), diabetes mellitus (3), cardiovascular disease (7), collagenosis (3), chronic bronchitis (2), neoplasm (l) or hydronephrosis/chronic pyelonephritis (2). 
